Although extrapolation regarding the role of TRMs in human neurodegenerative diseases in the absence of direct evidence needs to be tempered, upon reactivation of quiescent neurotropic viruses, bTRMs likely respond to de novo-produced viral Ag through rapid release of interferon (IFN)-γ [31]. Here, IFNG is linked to neurodegenerative disease.